[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212 220 6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 74, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 35, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 997010, "exercisedValue": 0, "unexercisedValue": 164999}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 638607, "exercisedValue": 0, "unexercisedValue": 51561}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 703319, "exercisedValue": 0, "unexercisedValue": 61875}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 67, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 305123, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Brandi L. Roberts CPA, M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Mack", "title": "Senior Vice President of Pharmaceutical Development & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Calitri", "title": "Vice President of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephanie  Fagan", "title": "Chief Corporate Affairs Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregg  Pratt Ph.D.", "title": "Chief Regulatory & Quality Assurance Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 7, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.88, "open": 10.87, "dayLow": 10.4646, "dayHigh": 11.1099, "regularMarketPreviousClose": 10.88, "regularMarketOpen": 10.87, "regularMarketDayLow": 10.4646, "regularMarketDayHigh": 11.1099, "payoutRatio": 0.0, "beta": 2.793, "forwardPE": -7.7956204, "volume": 1686082, "regularMarketVolume": 1686082, "averageVolume": 1819204, "averageVolume10days": 1601140, "averageDailyVolume10Day": 1601140, "bid": 10.63, "ask": 10.73, "bidSize": 3, "askSize": 7, "marketCap": 1038300992, "fiftyTwoWeekLow": 4.7, "fiftyTwoWeekHigh": 14.43, "allTimeHigh": 86.55, "allTimeLow": 0.015, "fiftyDayAverage": 11.6786, "twoHundredDayAverage": 8.60625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 883994112, "profitMargins": 0.0, "floatShares": 97624666, "sharesOutstanding": 97219193, "sharesShort": 11841922, "sharesShortPriorMonth": 9858103, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.12020001, "heldPercentInsiders": 0.00605, "heldPercentInstitutions": 0.41014, "shortRatio": 5.43, "shortPercentOfFloat": 0.120900005, "impliedSharesOutstanding": 97219193, "bookValue": 1.701, "priceToBook": 6.27866, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -168098000, "trailingEps": -1.98, "forwardEps": -1.37, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "enterpriseToEbitda": -5.828, "52WeekChange": 0.42969775, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 10.68, "targetHighPrice": 55.0, "targetLowPrice": 16.0, "targetMeanPrice": 25.63636, "targetMedianPrice": 23.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 209070000, "totalCashPerShare": 2.122, "ebitda": -151672752, "totalDebt": 40985000, "quickRatio": 3.196, "currentRatio": 3.3, "debtToEquity": 31.383, "returnOnAssets": -0.33949003, "returnOnEquity": -0.85592, "freeCashflow": -47703376, "operatingCashflow": -113936000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Mind Medicine (MindMed) Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1479220200000, "postMarketChangePercent": 0.18538606, "postMarketPrice": 10.6998, "postMarketChange": 0.019799232, "regularMarketChange": -0.2, "regularMarketDayRange": "10.4646 - 11.1099", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1819204, "fiftyTwoWeekLowChange": 5.9800005, "fiftyTwoWeekLowChangePercent": 1.2723405, "fiftyTwoWeekRange": "4.7 - 14.43", "fiftyTwoWeekHighChange": -3.75, "fiftyTwoWeekHighChangePercent": -0.25987527, "fiftyTwoWeekChangePercent": 42.969776, "dividendDate": 1582761600, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.98, "epsForward": -1.37, "epsCurrentYear": -2.1, "priceEpsCurrentYear": -5.085715, "fiftyDayAverageChange": -0.9986, "fiftyDayAverageChangePercent": -0.08550682, "twoHundredDayAverageChange": 2.0737505, "twoHundredDayAverageChangePercent": 0.24095868, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-27", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1763773013, "regularMarketTime": 1763758802, "exchange": "NMS", "messageBoardId": "finmb_631045282", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Mind Medicine (MindMed) Inc.", "regularMarketChangePercent": -1.83823, "regularMarketPrice": 10.68, "displayName": "Mind Medicine (MindMed)", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]